These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25692612)

  • 21. Bivalirudin with a post-procedure infusion versus heparin monotherapy for the prevention of stent thrombosis.
    Shah R; Latham SB; Porta JM; Naz A; Matin K; Rao SV
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):210-215. PubMed ID: 30636368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential mechanism of acute stent thrombosis with bivalirudin following percutaneous coronary intervention in acute coronary syndromes.
    Laine M; Frere C; Cuisset T; Paganelli F; Morange PE; Dignat-George F; Berbis J; Camoin-Jau L; Bonello L
    Int J Cardiol; 2016 Oct; 220():496-500. PubMed ID: 27390976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study).
    Patti G; Pasceri V; D'Antonio L; D'Ambrosio A; Macrì M; Dicuonzo G; Colonna G; Montinaro A; Di Sciascio G
    Am J Cardiol; 2012 Aug; 110(4):478-84. PubMed ID: 22583760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction.
    Leibundgut G; Pache J; Schulz S; Berger PB; Ferenc M; Gick M; Mehilli J; Kastrati A; Neumann FJ
    J Interv Cardiol; 2013 Dec; 26(6):623-9. PubMed ID: 24118114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial.
    Witzenbichler B; Mehran R; Guagliumi G; Dudek D; Huber K; Kornowski R; Stuckey TD; Fahy M; Parise H; Stone GW
    JACC Cardiovasc Interv; 2011 Jul; 4(7):760-8. PubMed ID: 21777884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleeding complications with regional adaptation of a prolonged bivalirudin regimen for ST-elevation acute myocardial infarction.
    Mueller E; Prabhu W; Desarno M; Sundaran P; Dauerman H
    Am J Cardiol; 2012 Dec; 110(11):1607-12. PubMed ID: 22901969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bivalirudin in ST-segment-elevation myocardial infarction: for better or worse?
    Mavrakanas TA; Chatzizisis YS
    Expert Rev Cardiovasc Ther; 2015; 13(8):893-5. PubMed ID: 26138859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bivalirudin versus unfractionated heparin for residual thrombus burden: a frequency-domain optical coherence tomography study.
    Vergallo R; Joye R; Barlis P; Jia H; Tian J; Soeda T; Minami Y; Hu S; Dauerman HL; Toma C; Chan J; Lee H; Biasucci LM; Crea F; Jang IK
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):575-82. PubMed ID: 25115992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of prolonged bivalirudin infusions following percutaneous coronary intervention.
    Moser LR; Nemerovski CW; Good KL
    Cardiovasc Drugs Ther; 2011 Jun; 25(3):267-76. PubMed ID: 21479645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stent malapposition, strut coverage and atherothrombotic prolapse after percutaneous coronary interventions in ST-segment elevation myocardial infarction.
    Leone AM; Rebuzzi AG; Burzotta F; De Maria GL; Gardi A; Basile E; Cialdella P; D'Amario D; Paraggio L; Porto I; Aurigemma C; Niccoli G; Trani C; Crea F
    J Cardiovasc Med (Hagerstown); 2019 Mar; 20(3):122-130. PubMed ID: 30601191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplasty.
    Lupi A; Rognoni A; Cavallino C; Secco GG; Reale D; Cossa G; Rosso R; Bongo AS; Cortese B; Angiolillo DJ; Jaffe AS; Porto I
    Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):487-96. PubMed ID: 26163529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of prolonged Bivalirudin infusion on ST-segment resolution following primary percutaneous coronary intervention (from the PROBI VIRI 2 study).
    Cortese B; Limbruno U; Severi S; De Matteis S; Diehl L; Pitì A
    Am J Cardiol; 2011 Nov; 108(9):1220-4. PubMed ID: 21855837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of prolonged bivalirudin infusion versus intraprocedural in preventing myocardial damage after percutaneous coronary intervention in patients with angina pectoris.
    Cortese B; Picchi A; Micheli A; Ebert AG; Parri F; Severi S; Limbruno U
    Am J Cardiol; 2009 Oct; 104(8):1063-8. PubMed ID: 19801025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.
    Han Y; Guo J; Zheng Y; Zang H; Su X; Wang Y; Chen S; Jiang T; Yang P; Chen J; Jiang D; Jing Q; Liang Z; Liu H; Zhao X; Li J; Li Y; Xu B; Stone GW;
    JAMA; 2015 Apr; 313(13):1336-46. PubMed ID: 25775052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.
    Stone SG; Serrao GW; Mehran R; Tomey MI; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Brener SJ; Dangas G; Stone GW
    Circ Cardiovasc Interv; 2014 Aug; 7(4):543-51. PubMed ID: 24939928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize Results of Stenting).
    Meneveau N; Souteyrand G; Motreff P; Caussin C; Amabile N; Ohlmann P; Morel O; Lefrançois Y; Descotes-Genon V; Silvain J; Braik N; Chopard R; Chatot M; Ecarnot F; Tauzin H; Van Belle E; Belle L; Schiele F
    Circulation; 2016 Sep; 134(13):906-17. PubMed ID: 27573032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction.
    Nairooz R; Sardar P; Amin H; Swaminathan RV; Kim LK; Chatterjee S; Feldman DN
    Am J Cardiol; 2014 Jul; 114(2):250-9. PubMed ID: 24890986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Lincoff AM; Steinhubl SR; Manoukian SV; Chew D; Pollack CV; Feit F; Ware JH; Bertrand ME; Ohman EM; Desmet W; Cox DA; Mehran R; Stone GW;
    JACC Cardiovasc Interv; 2008 Dec; 1(6):639-48. PubMed ID: 19463378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).
    Stone GW; Clayton T; Deliargyris EN; Prats J; Mehran R; Pocock SJ
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):15-20. PubMed ID: 24140664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction.
    Schulz S; Richardt G; Laugwitz KL; Morath T; Neudecker J; Hoppmann P; Mehran R; Gershlick AH; Tölg R; Anette Fiedler K; Abdel-Wahab M; Kufner S; Schneider S; Schunkert H; Ibrahim T; Mehilli J; Kastrati A;
    Eur Heart J; 2014 Sep; 35(34):2285-94. PubMed ID: 24816809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.